The introduction of generic imatinib represents a significant possibility for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a https://bimatoprosteyedrops823741.blogoxo.com/43635762/common-imatinib-a-cost-effective-alternative